Expression of roundabout receptor family members 1 and 2 in laryngeal squamous cell carcinoma and correlation with clinical and pathological parameters

Year 2018, Volume: 28 Issue: 1, 26 - 33, 05.03.2018

Ayşe Eren Ender Coşkunpınar Kadir Serkan Orhan Deniz Kanlıada Önder Şahin Mustafa Ömür Köse Turgay İsbir İlhan Yaylım

Abstract

Objectives: This study aims to investigate whether there is a role of ROBO-1, ROBO-2 and TGM-3 gene expression levels in the development of laryngeal cancer. Patients and Methods: The study was completed with 29 patients who underwent total or partial laryngectomy due to squamouscell laryngeal cancer. Gene expression analysis was performed by quantitative real-time polymerase chain reaction qRT-PCR . Expression ratios were transformed into fold changes and reported as relative expression. Obtained fold changes were compared between different tumor grades in addition to normal tissue samples. Results: The ROBO-1, ROBO-2 and TGM-3 genes were expressed at a lower level than the control group. Conclusion: Our study results showed that there was no correlation between ROBO-1, ROBO-2 and TGM-3 gene expression and development of laryngeal cancer.

Keywords

Gene expression, laryngeal carcinoma, Roundabout 1, TGM-3

References

• Dang S, Qu Y, Wei J, Shao Y, Yang Q, Ji M, et al. Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients. Diagn Pathol 2014;9:28.
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
• Tsiropoulos G, Papadas T, Triantaphyllidou Ie, Naxakis S, Markou K, Triaridis S, et al. Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients. Hippokratia 2013;17:220-7.
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
• Hashibe M, Brennan P, Benhamou S, Castellsaque X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007;99:777-89. Erratum in: J Natl Cancer Inst 2008;100:225.
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007;90:1-636.
• Lee YC, Boffetta P, Sturgis EM, Wei Q, Zhang ZF, Muscat J, et al. Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2008;17:1974-81.
• Gaudet MM, Olshan AF, Chuang SC, Berthiller J, Zhang ZF, Lissowska J, et al. Body mass index and risk of head and neck cancer in a pooled analysis of case- control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol 2010;39:1091-102.
• Negri E, Boffetta P, Berthiller J, Castellsague X, Curado MP, Dal Maso L, et al. Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer 2009;124:394-401.
• Dickinson RE, Duncan WC. The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system. Reproduction 2010;139:697-704.
• Seeger M, Tear G, Ferres-Marco D, Goodman CS. Mutations affecting growth cone guidance in Drosophila: genes necessary for guidance toward or away from the midline. Neuron 1993;10:409-26.
• Chen H, Zhang M, Tang S, London NR, Li DY, Zhang K. Slit-Robo signaling in ocular angiogenesis. Adv Exp Med Biol 2010;664:457-63.
• Zhou W, Yu W, Xie W, Huang L, Xu Y, Li X. The role of SLIT-ROBO signaling in proliferative diabetic retinopathy and retinal pigment epithelial cells. Mol Vis 2011;17:1526-36.
• Morlot C, Thielens NM, Ravelli RB, Hemrika W, Romijn RA, Gros P, et al. Structural insights into the Slit-Robo complex. Proc Natl Acad Sci U S A 2007;104:14923-8.
• Barathi VA, Weon SR, Tan QS, Lin KJ, Tong L, Beuerman RW. Transglutaminases (TGs) in ocular and periocular tissues: effect of muscarinic agents on TGs in scleral fibroblasts. PLoS One 2011;6:18326.
• Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003;4:140-56.
• Telci D, Griffin M. Tissue transglutaminase (TG2)--a wound response enzyme. Front Biosci 2006;11:867-82.
• Iannaccone M, Titta F, Serretiello E, De Vivo G, Martin A, Gentile V. Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases. Recent Pat CNS Drug Discov 2013;8:235-42.
• John S, Thiebach L, Frie C, Mokkapati S, Bechtel M, Nischt R, et al. Epidermal transglutaminase (TGase 3) is required for proper hair development, but not the formation of the epidermal barrier. PLoS One 2012;7:34252.
• Thibaut S, Cavusoglu N, de Becker E, Zerbib F, Bednarczyk A, Schaeffer C, et al. Transglutaminase-3 enzyme: a putative actor in human hair shaft scaffolding? J Invest Dermatol 2009;129:449-59.
• Candi E, Oddi S, Terrinoni A, Paradisi A, Ranalli M, Finazzi-Agró A, et al. Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro. J Biol Chem 2001;276:35014-23.
• Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am 2008;41:673-95.
• Mobley SR, Liu TJ, Hudson JM, Clayman GL. In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy. Arch Otolaryngol Head Neck Surg 1998;124:88-92.
• Anderson WF. End-of-the-year potpourri--1996. Hum Gene Ther 1996;7:2201-2.
• Mommersteeg MT, Andrews WD, Ypsilanti AR, Zelina P, Yeh ML, Norden J, et al. Slit-roundabout signaling regulates the development of the cardiac systemic venous return and pericardium. Circ Res 2013;112:465-75.
• Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
• Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H, et al. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001;410:948-52.
• Morlot C, Thielens NM, Ravelli RB, Hemrika W, Romijn RA, Gros P, et al. Structural insights into the Slit-Robo complex. Proc Natl Acad Sci U S A 2007;104:14923-8.
• Choi YC, Park GT, Kim TS, Sunwoo IN, Steinert PM, Kim SY. Sporadic inclusion body myositis correlates with increased expression and cross- linking by transglutaminases 1 and 2. J Biol Chem 2000;275:8703-10.
• Candi E, Oddi S, Terrinoni A, Paradisi A, Ranalli M, Finazzi-Agró A, et al. Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro. J Biol Chem 2001;276:35014-23.
• Kalinin AE, Kajava AV, Steinert PM. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays 2002;24:789-800.
• Eckert RL, Sturniolo MT, Broome AM, Ruse M, Rorke EA. Transglutaminase function in epidermis. J Invest Dermatol 2005;124:481-92.
• Kim CD, Seo EY, Sung YH, Kim HW, Seo YJ, Park JK, et al. Characterization of Ets-binding sequence of human transglutaminase 3 gene promoter. Exp Dermatol 2004;13:529-34.
• Wu X, Cao W, Wang X, Zhang J, Lv Z, Qin X, et al. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol Cancer 2013;12:151.
• Hitomi K, Horio Y, Ikura K, Yamanishi K, Maki M. Analysis of epidermal-type transglutaminase (TGase 3) expression in mouse tissues and cell lines. Int J Biochem Cell Biol 2001;33:491-8.
• Hitomi K. Transglutaminases in skin epidermis. Eur J Dermatol 2005;15:313-9.
• Hitomi K, Presland RB, Nakayama T, Fleckman P, Dale BA, Maki M. Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies. J Dermatol Sci 2003;32:95-103.
• He G, Zhao Z, Fu W, Sun X, Xu Z, Sun K. Study on the loss of heterozygosity and expression of transglutaminase 3 gene in laryngeal carcinoma. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:120-3.
• Negishi A, Masuda M, Ono M, Honda K, Shitashige M, Satow R, et al. Quantitative proteomics using formalin- fixed paraffin-embedded tissues of oral squamous cell carcinoma. Cancer Sci 2009;100:1605-11.
• Zhou WJ, Geng ZH, Chi S, Zhang W, Niu XF, Lan SJ, et al. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res 2011;21:609-26.
• Wang B, Xiao Y, Ding BB, Zhang N, Yuan Xb, Gui L, et al. Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 2003;4:19-29.
• Avci ME, Konu O, Yagci T. Quantification of SLIT- ROBO transcripts in hepatocellular carcinoma reveals two groups of genes with coordinate expression. BMC Cancer 2008;8:392.
• Latil A, Chêne L, Cochant-Priollet B, Mangin P, Fournier G, Berthon P, et al. Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer 2003;103:306-15.
• Liu W, Yu ZC, Cao WF, Ding F, Liu ZH. Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma. World J Gastroenterol 2006;12:3929-32.